Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phosphorylation on serines or threonines preceding proline (Ser/Thr-Pro) is a major signaling mechanism. The conformation of a subset of phosphorylated Ser/Thr-Pro motifs is regulated by the prolyl isomerase
Pin1
. Inhibition of
Pin1
induces apoptosis and may also contribute to neuronal death in Alzheimer's disease. However, little is known about the role of
Pin1
in cancer or in modulating transcription factor activity. Here we report that
Pin1
is strikingly overexpressed in human breast cancers, and that its levels correlate with cyclin D1 levels in tumors. Overexpression of
Pin1
increases cellular cyclin D1 protein and activates its promoter. Furthermore,
Pin1
binds
c-Jun
that is phosphorylated on Ser63/73-Pro motifs by activated JNK or oncogenic Ras. Moreover,
Pin1
cooperates with either activated Ras or JNK to increase transcriptional activity of
c-Jun
towards the cyclin D1 promoter. Thus,
Pin1
is up-regulated in human tumors and cooperates with Ras signaling in increasing
c-Jun
transcriptional activity towards cyclin D1. Given the crucial roles of Ras signaling and cyclin D1 overexpression in oncogenesis, our results suggest that overexpression of
Pin1
may promote tumor growth.
...
PMID:Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. 1143 33
Phosphorylation of serine or threonine residue preceding proline (Ser/Thr-Pro) is a key regulatory mechanism. The conformation of certain phosphorylated Ser/Thr-Pro bonds is regulated specifically by the prolyl isomerase
Pin1
. Inhibition of
Pin1
induces apoptosis and may contribute to neuronal death in Alzheimer's disease. It has been reported that
Pin1
is strikingly overexpressed in a subset of human tumors. The differential display screen revealed that
Pin1
increases the transcription of several target genes, including cyclin D1 and c-myc genes.
Pin1
cooperates with Ras signaling in increasing the transcriptional activity of
c-Jun
towards cyclin D1.
Pin1
also regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with adenomatous polyposis coli protein (APC). However, the analysis of
Pin1
expression has not been demonstrated in human oral squamous cell carcinoma (OSCC). We examined the expression of
Pin1
mRNA and protein in OSCC cell lines, and analyzed
Pin1
/cyclin D1/beta-catenin expression in OSCC clinical samples by immunohistochemical staining. We report that
Pin1
is overexpressed in OSCC and its level correlates with cyclin D1 level. These results indicate that
Pin1
is related to oncogenesis of OSCC.
...
PMID:Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. 1257 89
Phosphorylation on serine or threonine residue preceding proline (Ser/Thr-Pro) is a key regulatory mechanism. The conformation of certain phosphorylated Ser/Thr-Pro bonds is regulated specifically by the prolyl isomerase
Pin1
. It has been reported that
Pin1
is strikingly overexpressed in a subset of human tumors. A differential-display screen reveals that
Pin1
increases the transcription of several beta-catenin target genes, including those encoding cyclin D1 and c-Myc.
Pin1
cooperates with Ras signaling in increasing the transcriptional activity of
c-Jun
towards cyclin D1. We have previously reported that
Pin1
is overexpressed in oral squamous cell carcinoma (OSCC) and its level correlates with Cyclin D1 expression. However, the analysis of the relationship between
Pin1
and other cyclin genes has not been demonstrated in human OSCC. We examined
Pin1
mRNA and protein expressions in OSCC cell lines, and analyzed
Pin1
/cyclins expression by RT-PCR. We report that
Pin1
mRNA correlates with Cyclin D1 mRNA expression and the expression of many cyclin genes is associated with lymph node metastasis in OSCC. These results indicate that
Pin1
is a regulator of Cyclin D1 expression in OSCC and might have a role in oncogenesis; and the expression of many cyclin genes will be an indicator of lymph node metastasis in OSCC.
...
PMID:Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins. 1279 68
The activation of the activating protein-1 (AP-1) family of transcription factors, including c-Fos and
c-Jun
family members, is one of the earliest nuclear events induced by growth factors that stimulate extracellular signal-regulated kinases (ERKs). In the case of c-Fos, the activation of ERK leads to an increased expression of c-fos mRNA. In turn, we have recently shown that ERK phosphorylates multiple residues within the carboxylterminal transactivation domain (TAD) of c-Fos, thus resulting in its increased transcriptional activity. However, how ERK-dependent phosphorylation regulates c-Fos function is still poorly understood. In this regard, it has been recently observed that the prolyl isomerase
Pin1
can interact with proteins phosphorylated on serine or threonine residues that precede prolines (pS/T-P), such as the transcription factors p53 and
c-Jun
, thereby controlling their activity by promoting the cis-trans isomerization of these pS/T-P bonds. Here, we found that
Pin1
binds c-Fos through specific pS/T-P sites within the c-Fos TAD, and that this interaction results in an enhanced transcriptional response of c-Fos to polypeptide growth factors that stimulate ERK. Our findings suggest that c-Fos represents a novel target for the isomerizing activity of
Pin1
and support a role for
Pin1
in the mechanism by which
c-Jun
and c-Fos can cooperate to regulate AP-1-dependent gene transcription upon phosphorylation by mitogen-activated kinase (MAPK) family members.
...
PMID:Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. 1612 44
The peptidyl prolyl cis/trans isomerase
Pin1
specifically binds phosphorylated Ser/Thr-Pro protein motifs and catalyzes the cis/trans isomerization of the peptide bond. Accumulating studies have revealed that
Pin1
isomerase activity is regulated by its post-translational modifications, including phosphorylation and oxidation. Various transcription factors and regulators have been identified as substrates for
Pin1
. It enhances AP-1 activity via isomerization of both
c-Jun
and c-Fos for cellular proliferation and stabilizes the oncosuppressors p53 and p73 against DNA damage at the checkpoint. We demonstrated the association between the intracellular form of Notch1 (NIC) and
Pin1
by analyzing
Pin1
/p53 double-knockout mice.
Pin1
also regulates the post-transcriptional level of some cytokines, associated with asthma, that possess 3' untranslated region AU-rich elements (AREs) via interaction withAUF1, the nucleoprotein in the ARE-binding complex.
Pin1
has been identified as the molecular partner of tau and amyloid precursor protein (APP), the key factors of Alzheimer's disease (AD). It interacts with the phosphorylated Thr-231 of tau and regulates its activity to bind microtubules. It further interacts with the phosphorylated Thr-668 of APP and affects its metabolism. Thus,
Pin1
is probably involved in the pathogenesis of human diseases, including cancer, asthma, and AD, presenting an attractive target for future therapeutical drugs.
...
PMID:Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease. 1796 33
Developing neurons deprived of trophic support undergo apoptosis mediated by activation of
c-Jun
N-terminal kinases (JNK) and
c-Jun
, induction of the Bcl-2 homology 3-only protein Bim(EL), Bax-dependent loss of mitochondrial cytochrome c, and caspase activation. However, the mechanisms that regulate each of these events are only partially understood. Here we show that the prolyl isomerase
Pin1
functions as a positive regulator of neuronal death through a
c-Jun
-dependent mechanism. Ectopic
Pin1
promoted caspase-dependent death of NGF-maintained neurons that was associated with an accumulation of Ser(63)-phosphorylated
c-Jun
in neuronal nuclei and was partially dependent on Bax. Downregulating
Pin1
prior to NGF withdrawal suppressed the accumulation of phosphorylated
c-Jun
, inhibited the release of cytochrome c, and significantly delayed cell death.
Pin1
knockdown inhibited NGF deprivation-induced death to a similar extent in Bim (+/+) and Bim (-/-) neurons. The protective effect of
Pin1
knockdown was significantly greater than that caused by loss of Bim and nearly identical to that caused by a dominant negative form of
c-Jun
. Finally, cell death induced by ectopic
Pin1
was largely blocked by expression of dominant negative
c-Jun
. These results suggest a novel mechanism by which
Pin1
promotes cell death involving activation of
c-Jun
.
...
PMID:Pin1 promotes cell death in NGF-dependent neurons through a mechanism requiring c-Jun activity. 1841 64
Acquired resistance to tamoxifen (TAM) is a serious therapeutic problem in breast cancer patients. Here, we found that TAM-resistant MCF-7 cells (TAMR-MCF-7 cells) produced higher levels of vascular endothelial growth factor (VEGF) than control MCF-7 cells. Molecular analyses using reporter genes and Western blots supported the involvement of
c-Jun
/activator protein-1 and hypoxia-inducible factor 1alpha in enhanced VEGF transcription in TAMR-MCF-7 cells.
Pin1
, a peptidyl prolyl isomerase, was consistently overexpressed in TAMR-MCF-7 cells, and
c-Jun
/activator protein-1-dependent VEGF transcription in TAMR-MCF-7 cells was almost completely inhibited by
Pin1
siRNA and by the
Pin1
inhibitor juglone. Chick chorioallantoic membrane assays confirmed that the increased angiogenic intensity of TAMR-MCF-7 cells was significantly suppressed by
Pin1
inhibition. These results show that
Pin1
overexpression is closely associated with VEGF-mediated angiogenesis and suggest that
Pin1
is a potential therapeutic target of excessive angiogenesis in TAM-resistant breast cancer cases.
...
PMID:Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression. 1967 42
Pin1
specifically catalyzes the cis/trans isomerization of phospho-Ser/Thr-Pro bonds and plays an important role in many cellular events through the effects of conformational change on the function of its biological substrates, including cell division cycle 25 C (Cdc25C),
c-Jun
and p53.
Pin1
is overexpressed in many human cancer tissues, including breast, prostate and lung cancer. Its expression correlates with cyclin D1 levels, which contribute to cell transformation. Overexpression of
Pin1
promotes tumor growth, while inhibition of
Pin1
causes tumor cell apoptosis.
Pin1
plays an important role in oncogenesis and therefore may serve as an effective anticancer target. Many inhibitors of
Pin1
have been discovered, including several classes of designed inhibitors (alkene isosteres, reduced amides, indanyl ketones) and natural products (juglone, pepticinnamin E analogues, PiB and its derivatives obtained from a library screen).
Pin1
inhibitors could be used as a novel type of anticancer drug by blocking cell cycle progression. Therefore,
Pin1
represents a new diagnostic and therapeutic anticancer drug target.
...
PMID:Pin1 as an anticancer drug target. 1989 Apr 97
In normal neurons, neurofilament (NF) proteins are phosphorylated in the axonal compartment. However, in neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), NF proteins are aberrantly hyperphosphorylated within the cell bodies. The aberrant hyperphosphorylation of NF accumulations found in neurodegeneration could be attributable to either deregulation of proline-directed Ser/Thr kinase(s) activity or downregulation of protein phosphatase(s) activity. In this study, we found that protein phosphatase 2A (PP2A) expression is high in neuronal cell bodies and that inhibition of PP2A activity by okadaic acid (OA), microcystin LR (mLR), or fostriecin (Fos) leads to perikaryal hyperphosphorylation of NF. Peptidyl-prolyl isomerase
Pin1
inhibits the dephosphorylation of NF by PP2A in vitro. In cortical neurons,
Pin1
modulates the topographic phosphorylation of the proline-directed Ser/Thr residues within the tail domain of NF proteins by inhibiting the dephosphorylation by PP2A. Inhibition of
Pin1
inhibits OA-induced aberrant perikaryal phosphorylation of NF. Treatment of cortical neurons with OA or Fos prevents the general anterograde transport of transfected green fluorescent protein-high-molecular-mass (NF-H) into axons caused by hyperphosphorylation of NF-H, and inhibition of
Pin1
rescues this effect. Furthermore, inhibition of
Pin1
inhibits the OA- or Fos-induced neuronal apoptosis. We show that OA-induced hyperphosphorylation of NF is a consequence of dephosphorylation of NF and is independent of
c-Jun
N-terminal protein kinase, extracellular signal-regulated kinase, and cyclin-dependent kinase-5 pathways. This study highlights a novel signaling role of PP2A by
Pin1
and implicates
Pin1
as a therapeutic target to reduce aberrant phosphorylation of NF proteins in neurodegenerative disorders such as AD, PD, and ALS.
...
PMID:Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins. 1994 Jan 83
Pin1
[Protein Interacting with NIMA (never in mitosis A)] is a peptidyl prolyl cis-trans isomerase that isomerizes phospho-Serine/Threonine-Proline [p(S/T)-P] motifs of its target proteins.
Pin1
functions in concert with proline directed kinases such as cyclin-dependent protein kinases, extracellular signal-regulated kinases, and
c-Jun
N- terminal kinase, and protein phosphatases such as protein phosphatase 2A (PP2A) and PP2B, in the regulation of a wide range of cellular processes including cell division, DNA damage response, and gene transcription, and in susceptibility to cancer and neurodegenerative diseases. This review focuses on the roles of
Pin1
in neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Frontotemporal dementia associated with parkinsonism linked to chromosome 17.
Pin1
interacts with neuronal cytoskeletal proteins such as tau, amyloid-beta protein precursor, alpha-synuclein, and neurofilaments, often in association with phosphorylation events that influence their functions in the neuronal cytoskeleton. Overexpression of
Pin1
reduces WT tau stability but increases P301L mutant tau stability.
Pin1
associates with neurofilament H (NF-H) and modulates excitotoxic and oxidative stress induced perikaryal phosphorylation of NF-H.
Pin1
mediates the neural specific apoptosis machinery. The specific inhibitors of
Pin1
may have potential therapeutic implications in neurodegeneration.
...
PMID:Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration. 2011 May 89
1
2
3
Next >>